TACE Combined With Sintilimab Plus Bevacizumab Biosimilar in Hepatocellular Carcinoma (BCLC-C Stage ): a Prospective Single-arm Phase II Clinical Study
Clinical trial NCT04796025 · UNKNOWN
Trial details
- NCT number
- NCT04796025
- Sponsor
- Sun Yat-sen University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-23
- Primary completion
- 2023-08-31
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.